• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Enhancement of tumor blood flow and tumoricidal effect of doxorubicin by intraportal epinephrine in experimental liver metastasis.

作者信息

Bloom N D, Kroop E, Sadjadi M, Jacobs R, Ramaswamy G, Ackerman N B

机构信息

Department of Surgery, New York Medical College, Metropolitan Hospital Center, NY 10029.

出版信息

Arch Surg. 1987 Nov;122(11):1269-72. doi: 10.1001/archsurg.1987.01400230055010.

DOI:10.1001/archsurg.1987.01400230055010
PMID:3675191
Abstract

Laser Doppler capillary perfusion monitoring was performed in 25 Sprague-Dawley rats with solitary intrahepatic implants of Walker carcinosarcomas. Doses of intraportal epinephrine from 1 to 10 micrograms produced an immediate rise in capillary blood flow, reaching peak levels by 16 s. The increased flow lasted an average of 57 s. Because epinephrine selectively increased tumor blood flow, studies were performed to determine if enhancement of the chemotherapeutic effect of doxorubicin could be achieved. Forty-two rats with seven-day hepatic implants were treated sequentially with intraportal epinephrine (10 micrograms) and doxorubicin hydrochloride (10 mg/kg) or doxorubicin alone. After only two courses of chemotherapy, a significant difference in necrosis and cell viability was obtained in those animals treated with epinephrine intraportally prior to doxorubicin infusion. Enhancement of the tumoricidal effect of chemotherapy can be achieved by manipulating the blood flow to developing tumors pharmacologically.

摘要

相似文献

1
Enhancement of tumor blood flow and tumoricidal effect of doxorubicin by intraportal epinephrine in experimental liver metastasis.
Arch Surg. 1987 Nov;122(11):1269-72. doi: 10.1001/archsurg.1987.01400230055010.
2
The blood supply of experimental liver metastases. VIII. Increased capillary blood flow within liver tumors with administration of epinephrine.实验性肝转移瘤的血液供应。VIII. 注射肾上腺素后肝肿瘤内毛细血管血流增加。
Microcirc Endothelium Lymphatics. 1985;2(5):457-75.
3
Augmentation of the effect of doxorubicin with low-dose tumor necrosis factor in experimental liver metastasis.低剂量肿瘤坏死因子增强阿霉素对实验性肝转移的疗效
Mol Biother. 1990 Jun;2(2):121-4.
4
Evidence that epinephrine acutely redistributes blood flow to experimental intrahepatic tumors.肾上腺素可使血液迅速重新分配至实验性肝内肿瘤的证据。
Surgery. 1989 Feb;105(2 Pt 1):213-7.
5
The blood supply of experimental liver metastases. VII. Further studies on increased tumor vascularity caused by epinephrine.实验性肝转移瘤的血供。VII. 关于肾上腺素引起肿瘤血管增多的进一步研究。
Microcirc Endothelium Lymphatics. 1984 Oct;1(5):547-68.
6
Increased capillary flow in intrahepatic tumors due to alpha-adrenergic effects of catecholamines.
Cancer. 1988 Apr 15;61(8):1550-4. doi: 10.1002/1097-0142(19880415)61:8<1550::aid-cncr2820610811>3.0.co;2-d.
7
Changes in the hepatic perfusion index during the growth and development of experimental hepatic micrometastases.实验性肝微小转移灶生长发育过程中肝脏灌注指数的变化
Nucl Med Commun. 1987 Dec;8(12):995-1000. doi: 10.1097/00006231-198712000-00008.
8
The acute effects of hematoporphyrin derivative photoradiation on tumor and liver capillary blood flow.
Microcirc Endothelium Lymphatics. 1990 Aug-Oct;6(4-5):343-54.
9
Experimental studies on the role of the portal circulation in hepatic tumor vascularity.
Cancer. 1986 Oct 15;58(8):1653-7. doi: 10.1002/1097-0142(19861015)58:8<1653::aid-cncr2820580813>3.0.co;2-p.
10
The blood supply of experimental liver metastases. V. Increased tumor perfusion with epinephrine.实验性肝转移瘤的血供。V. 肾上腺素使肿瘤灌注增加。
Am J Surg. 1980 Nov;140(5):625-31. doi: 10.1016/0002-9610(80)90044-6.

引用本文的文献

1
Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow.持续区域性血管活性药物输注对肝转移血流的影响。
Br J Cancer. 1997;76(9):1205-10. doi: 10.1038/bjc.1997.534.